EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 327 filers reported holding EXELIXIS INC in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,776,171 | -19.6% | 1,408,519 | -29.7% | 0.06% | -9.8% |
| Q2 2023 | $38,267,700 | -11.1% | 2,002,496 | -9.7% | 0.06% | -14.1% |
| Q1 2023 | $43,031,348 | +50.9% | 2,216,968 | +24.7% | 0.07% | +44.9% |
| Q4 2022 | $28,521,508 | +43.2% | 1,778,149 | +40.0% | 0.05% | +40.0% |
| Q3 2022 | $19,920,000 | -13.6% | 1,270,487 | +14.7% | 0.04% | -10.3% |
| Q2 2022 | $23,060,000 | -8.9% | 1,107,661 | -0.8% | 0.04% | +21.9% |
| Q1 2022 | $25,304,000 | +136.5% | 1,116,258 | +90.7% | 0.03% | +166.7% |
| Q4 2021 | $10,698,000 | – | 585,265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |